We showed that IL-1 blockade using anakinra (which binds both human and mouse IL-1R1) did not significantly affect tumor response to cetuximab in Cal-27 (Fig. 2D) and SQ20B xenograft tumors (Fig. 2E). Here, IL1R1 is linked to neoplasm.